Keyphrases
Anesthesia
100%
Genetic Risk
100%
Myopathy
100%
Statin-induced Myopathy
100%
Malignant Hyperthermia
100%
RYR1 Gene
42%
Disease-causing mutations
28%
Muscle Disease
28%
Unknown Etiology
28%
Non-drug
28%
RYR1
28%
Drug-induced Myopathy
28%
Statins
14%
DNA Samples
14%
Inherited Disorders
14%
Genetic Susceptibility
14%
In(III)
14%
Drug-induced
14%
Ryanodine Receptor
14%
Gene mutation
14%
Genetic Liability
14%
Skeletal muscle
14%
Receptor Gene
14%
Muscle Pain
14%
Volatile Anesthetics
14%
Muscle Weakness
14%
Exercise-induced
14%
Pharmacogenetics
14%
Variable Penetrance
14%
Non-statins
14%
Disease Variants
14%
Heat Exposure
14%
Tolerant Control
14%
Pharmacology, Toxicology and Pharmaceutical Science
Genetic Risk
100%
Myopathy
100%
Malignant Hyperthermia
100%
Statin (Protein)
72%
Disease
27%
Muscle Disease
18%
Ryanodine Receptor
9%
Genetic Susceptibility
9%
Inhalation Anesthetic Agent
9%
Myalgia
9%
Pharmacogenetics
9%
Muscle Weakness
9%
Thermal Exposure
9%